Should Biotechnology Stock AVEO Pharmaceuticals, Inc. (AVEO) Be in Your Portfolio Wednesday?

Wednesday, June 22, 2022 01:06 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock AVEO Pharmaceuticals, Inc. (AVEO) Be in Your Portfolio Wednesday?

AVEO Pharmaceuticals, Inc. (AVEO) is near the top in its industry group according to InvestorsObserver. AVEO gets an overall rating of 73. That means it scores higher than 73 percent of stocks. AVEO Pharmaceuticals, Inc. gets a 92 rank in the Biotechnology industry. Biotechnology is number 38 out of 148 industries.

AVEO has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on AVEO!

See Full AVEO Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 73 means the stock is more attractive than 73 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With AVEO Pharmaceuticals, Inc. Stock Today?

AVEO Pharmaceuticals, Inc. (AVEO) stock is trading at $5.39 as of 1:02 PM on Wednesday, Jun 22, a gain of $0.59, or 12.29% from the previous closing price of $4.80. The stock has traded between $4.90 and $5.42 so far today. Volume today is more active than usual. So far 261,414 shares have traded compared to average volume of 168,810 shares. Click Here to get the full Stock Report for AVEO Pharmaceuticals, Inc. stock.